Tag: Satralizumab

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Satralizumab

Neuromyelitis Optica Spectrum Disorder Market Analysis Portrays a Promising Outlook of the ...

Added to Collection on: 2021-05-11 03:45:00

Tags for this article:

Autoimmune diseases
Orphan drugs
Neurological disorders
Clinical medicine
Organ systems
Monoclonal antibodies
Rare diseases
Inebilizumab
Neuromyelitis optica spectrum disorder
Satralizumab
Optic neuritis
NMO
Germany
France
Japan
United States
Italy
United Kingdom
Spain

Click the tags to see associated articles and topics

View Article Details
Roche data at EAN 2021 showcase significant impact of therapies across diverse neuroscience ...

Added to Collection on: 2021-06-15 04:52:30

Tags for this article:

Neurological disorders
Health
Autoimmune diseases
Monoclonal antibodies
Orphan drugs
Multiple sclerosis
Rare diseases
Neuromyelitis optica spectrum disorder
Ocrelizumab
Satralizumab
Genentech
Spinal muscular atrophy
United States
Roche Group

Click the tags to see associated articles and topics

View Article Details
Press Release : Roche data at EAN 2021 showcase -2-

Added to Collection on: 2021-06-15 04:52:30

Tags for this article:

Neurological disorders
Autoimmune diseases
Clinical medicine
Monoclonal antibodies
Branches of biology
Multiple sclerosis
Rare diseases
Orphan drugs
Neuromyelitis optica spectrum disorder
Ocrelizumab
Satralizumab
Interleukin 6

Click the tags to see associated articles and topics

View Article Details
Roche Presents Positive Clinical Data for Neurology Programs at EAN Annual Meeting

Added to Collection on: 2021-06-22 13:06:57

Tags for this article:

Neurological disorders
Health
Clinical medicine
Autoimmune diseases
Monoclonal antibodies
Orphan drugs
Rare diseases
Multiple sclerosis
Neuromyelitis optica spectrum disorder
Ocrelizumab
Satralizumab
Spinal muscular atrophy

Click the tags to see associated articles and topics

View Article Details
Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous ...

Added to Collection on: 2021-06-28 06:00:00

Tags for this article:

Branches of biology
Autoimmune diseases
Organ systems
Medical specialties
Orphan drugs
Rare diseases
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Satralizumab
Multiple sclerosis
Aquaporin 4
Interleukin 6
Roche Group

Click the tags to see associated articles and topics

View Article Details
Roche autoimmune disease drug disappoints in closely watched trial - BioPharma Dive

Added to Collection on: 2024-03-21 16:16:48

Tags for this article:

Monoclonal antibodies
Orphan drugs
Autoimmune diseases
Immunosuppressants
Quaternary ammonium compounds
Myasthenia gravis
Tocilizumab
Gravis
Chugai Pharmaceutical Co.
Eculizumab
Satralizumab
Neonatal fragment crystallizable receptor

Click the tags to see associated articles and topics

View Article Details
Truist maintains $74 target on Tourmaline Bio stock amid market selloff - Investing.com

Added to Collection on: 2024-04-17 19:11:54

Tags for this article:

Financial markets
Cyclosilicates
Gemstones
Tourmaline
Truist Financial
Market liquidity
Short
Satralizumab
Statin

Click the tags to see associated articles and topics

View Article Details
Safety Considerations for Ravulizumab in NMOSD: Sean Pittock, MD - NeurologyLive

Added to Collection on: 2024-04-23 19:08:11

Tags for this article:

Monoclonal antibodies
Orphan drugs
Autoimmune diseases
Rare diseases
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Multiple sclerosis
Aquaporin-4
Ravulizumab
Therapy

Click the tags to see associated articles and topics

View Article Details
Ravulizumab Outperforms NMOSD Therapies in Preventing Relapse, Meta-Analysis Reveals

Added to Collection on: 2024-05-14 19:11:40

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Inebilizumab
Satralizumab
Eculizumab
Multiple sclerosis
Ravulizumab
Relapse prevention
Aquaporin-4

Click the tags to see associated articles and topics

View Article Details
Reviewing Ravulizumab's Long-Term Profile as New NMOSD Treatment - NeurologyLive

Added to Collection on: 2024-05-18 19:10:46

Tags for this article:

Orphan drugs
Monoclonal antibodies
Neuromyelitis optica spectrum disorder
Satralizumab
Inebilizumab
Eculizumab
Ravulizumab
Multiple sclerosis
Horizon Therapeutics
Genentech

Click the tags to see associated articles and topics

View Article Details